It is currently Tue Aug 30, 2016 3:53 am
Carl Icahn raises the stakes for Big Pharma
The financier has set a high benchmark for bidders for the biotech firm. Fortune's John Simons explains why Big Pharma is likely to pay top dollar for a very risky asset.
Total posts 233931 • Total topics 25126 • Total members 16305